Harvard Men's Health Watch

Study shows female 'advantage' in melanoma survival

Women are less likely than men to die from skin cancer, according to a study in the Journal of Clinical Oncology. Even after adjusting for earlier diagnosis in women, the female survival advantage persisted.

The scientists looked closely at four treatment trials for melanoma, the most dangerous form of skin cancer. They found that women were 30% less likely to die overall from their melanoma. Of the estimated 8,790 deaths related to melanoma in 2011 in the United States, 35% were in women.

To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »